{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-01-202025-01-202025-01-212025-01-212025-01-222025-01-222025-01-232025-01-232025-01-242025-01-2417221611153050422794748572715015012012090906060303000
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-01-202025-01-202025-01-212025-01-212025-01-222025-01-222025-01-232025-01-232025-01-242025-01-241422271093043341312475641338141015015012012090906060303000
Download SVG
Download PNG
Download CSV
UBS Group has acquired shares in 29 companies, including Fortis Healthcare, Max Financial Services, Reliance Industries, Blue Star, and Hyundai Motor India, for a total of Rs 1,938 crore through open market transactions. Notable purchases include Rs 164 crore in Fortis Healthcare and Rs 144 crore in Max Financial Services. Following the acquisitions, shares of Fortis Healthcare, Blue Star, and Reliance Industries experienced declines on the National Stock Exchange.
UBS has revised its price target for Bright Horizons, lowering it to $130 from the previous $148. This adjustment reflects changing market conditions and expectations for the company’s performance.
Novo Nordisk A/S focuses on the design, manufacture, and marketing of pharmaceutical products, with 92.6% of sales from diabetes and obesity treatments and 7.4% from rare disease therapies. Geographically, 54.9% of sales come from the United States, followed by Europe-Middle East-Africa at 21.9%, and other regions.
General Electric (NYSE:GE) has seen significant changes in institutional ownership, with 74.77% of its stock held by hedge funds and other investors. Analysts have raised the price target for GE, with UBS Group increasing it to $235, suggesting a potential upside. The stock recently traded down 1.7% to $197.41, with a market cap of $213.66 billion and a P/E ratio of 34.69.
UBS has reiterated its Buy rating on Carnival stock, setting a target price of $31. This endorsement reflects confidence in the company's performance and potential for growth in the market.
UBS has lowered its price target for Bright Horizons to $130 from $148, maintaining a Neutral rating as the company anticipates moderate growth in its Full Service segment. Despite a solid 12.7% revenue growth over the past year, challenges such as foreign exchange impacts and a normalization of growth may lead to slightly below-market revenue guidance for 2025. Meanwhile, Baird and BMO have upgraded their ratings, reflecting confidence in the company's performance amid recent financial restructuring and strong results in its backup care segment.
UBS has reiterated a Buy rating on Carnival Corporation (NYSE: CCL) with a price target of $31, citing the potential financial benefits from the new private island, Celebration Key. Analysts project that the island could generate around $150 million in EBITDA in its first full year, contributing to a significant yield improvement by 2026. Recent adjustments from other analysts reflect a positive outlook, with Carnival's net debt to adjusted EBITDA ratio expected to decrease from 4.3x to 3.8x by FY2025.
UBS maintains a Buy rating on Gartner, setting a price target of $592, while Barclays upgraded the stock to Overweight with a $600 target, reflecting optimism despite potential fiscal challenges. Gartner reported a 5% revenue increase to $1.5 billion in Q3 2024, driven by a 9% rise in enterprise contract value and a $300 million insurance payout from conference cancellations. The company has raised its full-year guidance for revenue and other key metrics, showcasing strong financial health amid executive retirements.
UBS has maintained a Neutral rating on Harley-Davidson stock with a price target of $35, citing concerns over declining U.S. retail sales, which may have dropped nearly 10% in recent months. The company's stricter credit requirements are seen as a barrier to potential buyers, contributing to sluggish sales. Despite these challenges, Harley-Davidson reported a 13% drop in global retail sales in Q3 2024 but continues to show financial stability with a strong free cash flow yield and a consistent dividend payout.
Scape Australia has transformed its flagship student accommodation vehicle into a A$6 billion ($3.8 billion) open-ended core fund, featuring a portfolio of 16,000 beds across 33 operational assets. UBS Asset Management joins existing investors such as APG, Bouwinvest, National Pension Service of Korea, and Ivanhoe Cambridge.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.